Skip to content

The Effect of Adenomoyosis on Pregnancy Outcomes

Adverse Obstetrical Outcomes for Women With Adenomyosis

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04894292
Enrollment
150
Registered
2021-05-20
Start date
2021-05-20
Completion date
2022-12-31
Last updated
2021-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis, Pregnancy Complications

Keywords

adenomyosis, pregnancy complications, MUSA classification, ultrasound

Brief summary

Adenomyosis can be defined as the settling of endometrial gland cells in the myometrium and deformity in the uterus and the prevalence of adenomyosis is according to the patient population and countries around 20%. There are recent publications reporting that this rate increases up to 50% in women dealing with infertility. In adenomyosis, where uterine morphology is affected, it is not thought that the uterus, which is expected to provide many morphological adaptations during pregnancy, will not be affected. Therefore, in this prospective study, it was planned to investigate the effects of adenomyosis during pregnancy. For this study the presence of adenomyosis will be questioned by using ultrasonographic morphological uterine limitation (MUSA) in women who apply to the outpatient clinic with suspicion of pregnancy and undergo transvaginal ultrasonography for the diagnosis of pregnancy before sixth gestational week. Patients will be divided into two groups according to the presence of adenomyosis and pregnancy complications such as preterm labor, premature rupture of membranes, cesarean section rates, preeclampsia, fetal malpresentation and preeclampsia will be compared between the groups.

Interventions

OTHERNon intervention

During the study there is no extra intervention planned for the participants.

Sponsors

Tepecik Training and Research Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Age between 18-35 years * Being diagnosed before the 6th gestational week * Having all pregnancy follow-ups and deliveries in our hospital

Exclusion criteria

* Previous uterine surgery * Multiple pregnancies * Pregnant women with uterine malformations * Pregnant women with fetal anomalies * Those who got pregnant using assisted reproductive technique

Design outcomes

Primary

MeasureTime frameDescription
Pregnancy complication15 monthPreterm labour

Secondary

MeasureTime frameDescription
Pregnancy complication16 monthplacental anomalies

Countries

Turkey (Türkiye)

Contacts

Primary ContactAbdurrahman Hamdi İnan, Assoc. Prof.
ahamdiinan@gmail.com(0232) 373 89 21

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026